Research Output | Dar Al-hikmah Library | IIUM Only
BACKGROUND AND OBJECTIVES: The number of cardiometabolic disease Type 2 diabetes mellitus (T2DM) patients are expected to increase to 552 million people worldwide by 2030. Current treatment options potential therapeutic benefits of natural products such as Lepidium meyenii (Maca) and marine collagen peptides (MCP), as well as Blackbelt® coffee on